Name: generation of plasmid vectors expressing flag-tagged proteins under the regulation of human elongation factor-1&#945; promoter using gibson assembly
Uploaded: 2015-02-09T14:00:00
Duration: 10 min 18 s
Description: Watch this Scientific Journal Video about Generation of Plasmid Vectors Expressing FLAG-tagged Proteins Under the Regulation of Human Elongation Factor-1Î± Promoter Using Gibson Assembly at JoVE.com

We would like to thank Michaela Jansen at the Texas Tech University Health Sciences Center, Lubbock, TX and Mladen Yovchev at the University of Pittsburgh Medical Center, Pittsburgh, PA for the generously providing pcDNA 3.1 myc-His (A) and hEF1&#945; promoter containing plasmids. Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under award number R01HD037109 (to CCM). Additional support was from the Laura W. Bush Institute for Women&#8217;s Health (to CCM and PNG). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
The authors declare that they have no competing financial interests.

1. In Silico Design of the Plasmid and Generation of the Overlapping Primers
NOTE: The objective of this step is to assemble complete nucleotide sequence of the construct and design the primers to be used to generate fragments with overlapping ends for GA cloning.
<ol>
	<li>Design a continuous nucleotide sequence to represent the final plasmid.</li>
	<li>Obtain or list the actual plasmids and DNA fragments that will be used as templates in PCR. 
	NOTE: DNA fragments that are not readily available &#8212; such as different combination of tags and promoters &#8212; can be ordered as a single or multiple synthetic double-stranded DNA fragments (sDNA). These fragments are commercially available at relatively low cost and can be up to 2 kb in length (see Table of Materials).</li>
	<li>Divide the continuous nucleotide sequence of the construct assembled in step 1.1 into DNA fragments suitable for PCR. Confirm that the fragments match available plasmids and sDNA fragments. Avoid DNA fragments smaller than 200 nt.</li>
	<li>Access the primer generation tool (see Table of Equipment). Select the &#8220;Set Preferences&#8221; menu. Choose appropriate settings by clicking on the &#8220;CHANGE PREFS&#8221; tab in the &#8220;Change Gibson Assembly Settings&#8221; pop-up window. 
	NOTE: Primer design can also be performed without the use of the primer generation tool. However, the use of the primer generation tool simplifies the process.</li>
	<li>Start building the construct by selecting the &#8220;Build Construct&#8221; menu. Insert the split DNA fragments in the primer generation tool sequentially from 5&#8217; to 3&#8217; end. 
	NOTE: The DNA fragment used as a plasmid backbone can be conveniently divided into two pieces. In the final PCR product the 5&#8217; end of this first fragment and the 3&#8217; end of the last fragment are linked together in one continuous DNA fragment representing the vector backbone.</li>
	<li>Paste the first DNA fragment representing the 5&#8217; end of the vector DNA in FASTA format (a text-based representation of nucleotide sequence) into the &#8220;Enter Vector or Insert Fragment&#8221; pop-up window. Name the DNA fragment. Choose the appropriate way to obtain the DNA fragment, either as PCR, RE Digest or Synthesis. Click on the &#8220;CONTINUE&#8221; tab.</li>
	<li>If there is a need to add extra nucleotides/restriction sites at the junction of the final construct use the &#8220;Fwd or Rev primer spacer&#8221; spaces provided in the &#8220;Add an insert fragment to the assembly&#8221; window. Add extra nucleotides/restriction sites to only one of the DNA fragments and not to both fragments. Click on &#8220;DONE&#8221; tab.</li>
	<li>Repeat for all of the fragments until the construct is complete. Select the &#8220;View Primers&#8221; menu and review the primer sequences.</li>
	<li>Repeat for all constructs (vector backbones and inserts), or for DNA fragments that are different.</li>
</ol>
2. Amplification of the DNA Fragments by PCR Using Hot Start Proofreading DNA Polymerase (2x Master Mix)
NOTE: The objective to this step is to obtain sufficient DNA for the assembly reaction using PCR.
<ol>
	<li>Purchase the PCR primers designed in the previous step as desalted products and at the smallest possible scale. Dilute them to 10 &#181;M in water or TE (10 mM Tris-HCl, pH 7.9, 1 mM EDTA).</li>
	<li>Purchase DNA fragments that are not readily available as sDNA fragments.</li>
	<li>Dilute all DNA fragments, including the sDNA fragments that will be used as templates for the PCRs to 1 ng/&#181;l in water.</li>
	<li>Assemble the PCR reactions at room temperature. Briefly, use 2.5 &#181;l (from 10 &#181;M stock solution) of the each respective primer of the primer pair, 1 &#181;l (from 1 ng/&#181;l stock solution) of the template DNA fragment, 25 &#181;l of hot start proofreading DNA polymerase (DNA pol; 2x master mix; see Table of Materials) and 19 &#181;l water. Mix the tube by gentle flicking and collect the liquid droplets by brief centrifugation.</li>
	<li>Amplify simultaneously in separate tubes DNA fragments of similar size according to the recommendations for the DNA pol. Perform 25 - 28 PCR cycles or determine the number of cycles that produce sufficient DNA yield.</li>
	<li>Run 10% of the PCR reaction volume (5 &#181;l) on a standard agarose gel electrophoresis stained with ethidium bromide (0.2 &#181;g/ml final concentration). Ensure that a single DNA band representing the PCR product is visible. Determine the size and relative amount of the DNA fragments using DNA molecular weight standards. If necessary, repeat the PCR to obtain sufficient amount of DNA fragments.</li>
</ol>
3. DpnI Digestion of the PCR Products
NOTE: The objective of this step is to digest residual plasmid template DNA from the PCRs in Section 2. DpnI will digest plasmid DNA only if it is methylated, such as occurs to plasmid DNA grown in dam+ bacterial strains. Therefore, do not treat with DpnI if plasmid DNA will be used as a DNA fragment in the GA reaction.
<ol>
	<li>Add 2 &#181;l of DpnI restriction enzyme to the 45 &#181;l of the PCR products produced in Section 2. Incubate at 37 &#176;C for 1 hr. Proceed with Section 4 or freeze at -20 &#176;C until needed.</li>
</ol>
4. Purification and Concentration of the DNA Fragments over DNA Purification Magnetic Beads
NOTE: The objective of this step is to purify and concentrate the PCR products obtained in Sections 2 and 3. Other PCR purification methods may be used as well.
<ol>
	<li>Equilibrate the DNA purification magnetic beads to room temperature. Re-suspend the beads by brief vortexing.</li>
	<li>Transfer the PCRs pre-digested with DpnI to a 1.5 ml tubes and add 81 &#181;l of DNA purification magnetic beads to each tube. Incubate the mixture at room temperature for 10 min.</li>
	<li>Place the tubes on the magnetic collector for about 2 min. Discard the clear liquid using a pipette. Wash twice with 200 &#181;l of 80% ethanol for 30 sec.</li>
	<li>Allow the pellets to dry. Keep the lid of the tubes open, with the tubes positioned on the magnetic collector.</li>
	<li>Re-suspend the dried beads in 10 &#181;l of 10 mM Tris-HCl, pH 8.0. Incubate at room temperature for 2 min. Spin briefly to collect the liquid at the bottom of the tubes.</li>
	<li>Position the tubes on the magnetic collector for 2 min. Remove 8.5 - 10 &#181;l of the clear solution and place it in a new pre-labeled tube. Determine the concentration of the DNA fragments by UV spectroscopy (see Table of Equipment).</li>
</ol>
5. Assembly Cloning Reaction and Transformation of the Products in E. coli
NOTE: The objective to this step is to calculate 3:1 ratio of insert:vector and perform the assembly reaction.
<ol>
	<li>Use at least 100 ng of DNA fragment representing the vector backbone or DNA fragment carrying the selective marker. Calculate the 3-fold molar excess for the DNA fragments that will be used as inserts.</li>
	<li>Convert the molar-excess in ng needed of each particular insert. 
	NOTE: A convenient way to do the calculations is to use a web-based application (see Table of Equipment).</li>
	<li>Mix calculated amounts of DNA fragments in a PCR tube, adjust the volume to 10 &#181;l. Add 10 &#181;l of the GA master mix (2x, see Table of Materials). Incubate the reaction at 50 &#176;C for 1 hr for assembly of 4 - 6 fragments or 15 min for assembly of 2-3 fragments in a PCR thermal cycler.</li>
	<li>Proceed with transformation of the assembly product in competent E. coli or freeze the products at -20 &#176;C, until needed.</li>
	<li>Follow the transformation procedure that accompanies the chemical or electro competent cells. Usually, use 2 &#181;l of the assembly reaction per transformation reaction.</li>
	<li>After the transformation is complete, spread the transformed cells on agar plates supplemented with the appropriate selective antibiotic.</li>
</ol>
6. Plasmid Isolation, Restriction Enzyme Digestion and Sequencing
NOTE: The objective of this step is to isolate plasmid DNA from E. coli, then to verify the construct by restriction digestion and sequencing.
<ol>
	<li>Propagate several single colonies for mini preps and plasmid isolation. Use 2-5 ml overnight LB liquid culture supplemented with appropriate antibiotic. Isolate the corresponding plasmids by following the procedure that is described in the mini prep kit that is used.</li>
	<li>Determine the amount and concentration of the plasmids obtained using spectrophotometer.</li>
	<li>Perform restriction digestion with one or several restriction endonucleases to ~0.5 &#181;g of the purified plasmids. Use restriction enzymes that provide distinct pattern of digestion characteristic for the DNA constructs.</li>
	<li>Confirm DNA cloning success by DNA sequencing using specific or standard primers. Analyze the sequencing data for accuracy.</li>
</ol>

<ol>
	<li>Gibson, D. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Enzymatic+assembly+of+overlapping+DNA+fragments.">Enzymatic assembly of overlapping DNA fragments.</a> Methods in enzymology. 498, 349-361 (2011).</li><li>Gibson, D. G., Smith, H. O., Hutchison, C. A., Venter, J. C., Merryman, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Chemical+synthesis+of+the+mouse+mitochondrial+genome.">Chemical synthesis of the mouse mitochondrial genome.</a> Nature methods. 7, 901-903 (2010).</li><li>Gibson, D. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Enzymatic+assembly+of+DNA+molecules+up+to+several+hundred+kilobases.">Enzymatic assembly of DNA molecules up to several hundred kilobases.</a> Nature methods. 6, 343-345 (2009).</li><li>Bowtell, D. D., Johnson, G. R., Kelso, A., Cory, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Expression+of+genes+transferred+to+haemopoietic+stem+cells+by+recombinant+retroviruses.">Expression of genes transferred to haemopoietic stem cells by recombinant retroviruses.</a> Molecular biology &amp; medicine. 4, 229-250 (1987).</li><li>Challita, P. M., Kohn, D. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Lack+of+expression+from+a+retroviral+vector+after+transduction+of+murine+hematopoietic+stem+cells+is+associated+with+methylation+in+vivo.">Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo.</a> Proceedings of the National Academy of Sciences of the United States of America. 91, 2567-2571 (1994).</li><li>Lutzko, C., Senadheera, D., Skelton, D., Petersen, D., Kohn, D. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Lentivirus+vectors+incorporating+the+immunoglobulin+heavy+chain+enhancer+and+matrix+attachment+regions+provide+position-independent+expression+in+B+lymphocytes.">Lentivirus vectors incorporating the immunoglobulin heavy chain enhancer and matrix attachment regions provide position-independent expression in B lymphocytes.</a> Journal of Virology. 77, 7341-7351 (2003).</li><li>Meilinger, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Np95+interacts+with+de+novo+DNA+methyltransferases,+Dnmt3a+and+Dnmt3b,+and+mediates+epigenetic+silencing+of+the+viral+CMV+promoter+in+embryonic+stem+cells.">Np95 interacts with de novo DNA methyltransferases, Dnmt3a and Dnmt3b, and mediates epigenetic silencing of the viral CMV promoter in embryonic stem cells.</a> EMBO reports. 10, 1259-1264 (2009).</li><li>Chan, K. K., Wu, S. M., Nissom, P. M., Oh, S. K., Choo, A. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Generation+of+high-level+stable+transgene+expressing+human+embryonic+stem+cell+lines+using+Chinese+hamster+elongation+factor-1+alpha+promoter+system.">Generation of high-level stable transgene expressing human embryonic stem cell lines using Chinese hamster elongation factor-1 alpha promoter system.</a> Stem cells and development. 17, 825-836 (2008).</li><li>Chung, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Analysis+of+different+promoter+systems+for+efficient+transgene+expression+in+mouse+embryonic+stem+cell+lines.">Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines.</a> Stem cells. 20, 139-145 (2002).</li><li>Qin, J. Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Systematic+comparison+of+constitutive+promoters+and+the+doxycycline-inducible+promoter.">Systematic comparison of constitutive promoters and the doxycycline-inducible promoter.</a> PloS one. 5, e10611 (2010).</li><li>Lund, A., Knudsen, S. M., Vissing, H., Clark, B., Tommerup, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Assignment+of+human+elongation+factor+1alpha+genes:+EEF1A+maps+to+chromosome+6q14+and+EEF1A2+to+20q13.3.">Assignment of human elongation factor 1alpha genes: EEF1A maps to chromosome 6q14 and EEF1A2 to 20q13.3.</a> Genomics. 36, 359-361 (1996).</li><li>Wallace, A. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Two+distinct+forms+of+the+64,000+Mr+protein+of+the+cleavage+stimulation+factor+are+expressed+in+mouse+male+germ+cells.">Two distinct forms of the 64,000 Mr protein of the cleavage stimulation factor are expressed in mouse male germ cells.</a> Proceedings of the National Academy of Sciences of the United States of America. 96, 6763-6768 (1999).</li><li>MacDonald, C. C., McMahon, K. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Tissue-specific+mechanisms+of+alternative+polyadenylation:+testis,+brain,+and+beyond.+Wiley+interdisciplinary+reviews.">Tissue-specific mechanisms of alternative polyadenylation: testis, brain, and beyond. Wiley interdisciplinary reviews.</a> RNA. 1, 494-501 (2010).</li><li>Sabath, I., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=3'-End+processing+of+histone+pre-mRNAs+in+Drosophila:+U7+snRNP+is+associated+with+FLASH+and+polyadenylation+factors.">3'-End processing of histone pre-mRNAs in Drosophila: U7 snRNP is associated with FLASH and polyadenylation factors.</a> Rna. 19, 1726-1744 (2013).</li><li>Yang, X. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+complex+containing+the+CPSF73+endonuclease+and+other+polyadenylation+factors+associates+with+U7+snRNP+and+is+recruited+to+histone+pre-mRNA+for+3'-end+processing.">A complex containing the CPSF73 endonuclease and other polyadenylation factors associates with U7 snRNP and is recruited to histone pre-mRNA for 3'-end processing.</a> Molecular and cellular biology. 33, 28-37 (2013).</li><li>Grozdanov, P. N., Macdonald, C. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=High-Throughput+Sequencing+of+RNA+Isolated+by+Cross-Linking+and+Immunoprecipitation+(HITS-CLIP)+to+Determine+Sites+of+Binding+of+CstF-64+on+Nascent+RNAs.">High-Throughput Sequencing of RNA Isolated by Cross-Linking and Immunoprecipitation (HITS-CLIP) to Determine Sites of Binding of CstF-64 on Nascent RNAs.</a> Methods in molecular biology. 1125, 187-208 (2014).</li><li>Youngblood, B. A., Grozdanov, P. N., MacDonald, C. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=CstF-64+supports+pluripotency+and+regulates+cell+cycle+progression+in+embryonic+stem+cells+through+histone+3'+end+processing.">CstF-64 supports pluripotency and regulates cell cycle progression in embryonic stem cells through histone 3' end processing.</a> Nucleic acids research. , (2014).</li><li>Engler, C., Kandzia, R., Marillonnet, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+one+pot,+one+step,+precision+cloning+method+with+high+throughput+capability.">A one pot, one step, precision cloning method with high throughput capability.</a> PloS one. 3, e3647 (2008).</li><li>Irwin, C. R., Farmer, A., Willer, D. O., Evans, D. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=In-fusion(R)+cloning+with+vaccinia+virus+DNA+polymerase.">In-fusion(R) cloning with vaccinia virus DNA polymerase.</a> Methods in molecular biology. 890, 23-35 (2012).</li><li>Annaluru, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Total+synthesis+of+a+functional+designer+eukaryotic+chromosome.">Total synthesis of a functional designer eukaryotic chromosome.</a> Science. 344, 55-58 (2014).</li><li>Gibson, D. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Creation+of+a+bacterial+cell+controlled+by+a+chemically+synthesized+genome.">Creation of a bacterial cell controlled by a chemically synthesized genome.</a> Science. 329, 52-56 (2010).</li></ol>

Open Access publication and production fees were supplied by New England BioLabs Inc.

Successful use of GA cloning should be always preceded by a careful design of the complete construct (Figure 2 and Figure 3).
Careful verification of the primer sequences designed by the primer generation tool is also highly recommended. Primers for GA may be generated without the use of the primer generation tool. However, use of the tool is highly recommend, because it simplifies the process. Generally, the primer for GA cloning must have two functionally different sequences. The first sequence is DNA fragment-specific, and allows the amplification of the fragment using PCR. The second sequence overlaps with the adjacent fragment, which is necessary for GA assembly. A typical DNA-fragment-specific sequence would be 18&#8211;22 nt in length. DNA-fragment specific sequences used to amplify the same DNA must have similar melting temperatures and GC content. Overlapping sequence should be at least of 15 nt in length with a melting temperature of at least 48 &#176;C. The assembly of more than 4 DNA fragments will require the overlapping sequence to be at least 20 nt. Longer overlaps will allow increased specificity of the annealing resulting in more properly assembled DNA fragments. It is recommended to avoid sequences that are skewed in their GC or AT content in developing overlapping sequences, because skewed sequences might compromise proper DNA assembly.
We also suggest using as a negative control, which should not produce any drug-resistant bacterial colonies, just the DNA fragment corresponding to the vector backbone in a GA reaction. Alternatively, one of the DNA fragments comprising the &#8220;inserts&#8221; may be omitted from the GA reaction, which should also result in no drug-resistant bacterial colonies. The reason no colonies will grow will be the lack of overlapping ends of the adjacent DNA fragments, which will render the assembly of a complete plasmid.
In the protocol described, overlapping sequences of 25 nt to generate the primer sets were used, because of the number of DNA fragments used (Figure 3). The recommendation of the primer generation tool website (see Table of Equipment) is to use at least 20 nt overlapping sequences to assemble 4 - 6 DNA fragments. In addition, longer overlapping sequence will ensure the proper complementation of the DNA strands (see Figure 1) increasing the number of accurately assembled products.
Currently, several systems for seamless cloning are available. However, some of these systems still use restriction enzymes (i.e., Golden Gate cloning18). Others use proprietary blends of enzymes based on vaccinia virus DNA polymerase and single-strand DNA binding protein from the same biological source19. Both systems are limited in comparison to GA by the shorter length of overlapping sequences. Because shorter overlapping sequences might not provide sufficient specificity to the annealing step of adjacent DNA fragments, rendering the proper assembly of more than 23 DNA fragments problematic. These shortcomings are not present in the GA system.
The size of the DNA fragments to be amplified should be also considered so as not to exceed the size reliably amplifiable by PCR (i.e., less than 8 kbp in length). Even with the improvements in the function of DNA polymerases in the last 10 years, large DNA fragments will be amplified with less efficiency and accuracy. If needed, larger DNA fragments might be obtained from other sources alternative to PCR, e.g., by plasmid isolation and appropriate DNA digestion with restriction enzymes. Specifically, for the protocol described in the current manuscript, our rational to use PCR was based on the size of the available DNA fragments, which were all less than 5 kbp. If there is more than one PCR product identified by agarose gel electrophoresis, gel purification of the desirable fragment size is recommended using any of the available molecular biology techniques or appropriate kits. In the current protocol a thermostable DNA polymerase is used (see Table of Materials). However any DNA polymerase providing high fidelity and yield will be suitable to be used with this protocol. If high-fidelity DNA polymerases different than described in the protocol are available, use the set up conditions as described in the respective manuals. In the current protocol, chemically competent E. coli cells are used that are supplied with the GA kit. Alternatively, chemically or electro competent E. coli strains such as DH5&#945; or DH10B can be used.
The assembly cloning 2x master mix is easy to use with minimal hands-on time. However, accurate pipetting is required because of the small volumes needed to be mixed together. Good molecular biology technique needs to be exercised at all times as well.
The GA cloning offers unlimited possibilities for a construction of DNA fragments, plasmids and vectors, which are longer than 3 kbp in size. In addition it has a broader impact in the field of synthetic biology, because it allows synthesis and assembly of, for example, an entire bacterial (Mycoplasma mycoides) genome or a yeast (Saccharomyces cerevisiae) chromosome20,21. The technique is also applicable to conventional cloning needs to generate seamless constructs.
In conclusion, GA cloning offers rapid, reliable and flexible alternative to the conventional DNA cloning procedure.

Conventional DNA cloning procedures rely on the use of restriction enzymes to cleave the DNA and DNA ligase to join the DNA fragments together. Generation of custom expression constructs containing different DNA fragments is a sequential procedure that includes cleavage of the DNA with one and/or multiple restriction endonucleases and the subsequent insertion of DNA fragments through ligation. The major drawback of this procedure is that suitable restriction enzymes for one of the DNA fragments might be difficult to identify (i.e., might have several cleavage sites) rendering successful DNA cloning of the full-length protein of interest impossible. Therefore, generation of custom expression constructs under the transcriptional regulation of efficient cell type-specific promoters with customized protein-tags requires very careful design. It is also a time- and labor-consuming technique. Recently, several reports described methodologies to assemble multiple different synthetic DNA fragments in a continuous sequence at the same time in either one- or two-step reactions without the use of restriction enzymes1-3. The one-step cloning reaction (excluding all preparatory steps), depends on the use of a blend of DNA exonuclease, DNA polymerase, DNA ligase2,3 and the overlapping ends of DNA fragments (Figure 1). Since there is no use of restriction enzymes, DNA fragments of any size and sequence composition (excluding highly repetitive sequences) can be fused together in a seamless construct. Recently, a commercial kit (Gibson assembly; GA) for the one-step cloning reactions became available. This kit allows rapid and cost efficient assembly of any DNA fragments in a single vector with customized promoters and protein tags.
The widely available plasmid expression vectors used to express exogenous proteins in mammalian cell culture models are often under the transcriptional regulation of the viral cytomegalovirus (CMV) or Simian virus 40 (SV40) promoters. These viral promoters provide robust transient expression of the exogenous proteins in the majority of mammalian cell culture based models. However, generation of cell lines stably expressing exogenous proteins is often unsuccessful because of transcriptional silencing of the CMV or SV40 promoters during the establishment process4,5. In addition, the SV40 and CMV viral promoters will not sufficiently promote the expression of exogenous proteins in cells from the lymphoid lineage or embryonic stem cells6,7. The solution to the inherent limitation of viral promoters is to use strong constitutive non-viral promoters8-10. One well-characterized strong constitutive non-viral promoter of human origin is the elongation factor 1&#945; (hEF1&#945;) promoter (hEF1&#945; is involved in the catalysis of the GTP-dependent association of aminoacyl-tRNA to ribosomes11). However, expression vectors containing the hEF1&#945; promoter are not as widely available as the viral-promoter containing plasmids, especially ones also containing 3&#215;FLAG at the amino terminal end of the protein of interest.
The 64,000 MW cleavage stimulation factor protein (CstF-64) is involved in the 3&#8217; end processing of most mRNAs12,13, including replication-dependent histone mRNAs14,15. CstF-64 is expressed in all somatic tissues12. Its RNA recognition motif binds to GU-rich RNA sequences on nascent transcripts downstream of the cleavage and polyadenylation site16. This binding of CstF-64 to the pre-mRNA promotes efficient endonucleolytic cleavage of the nascent transcript.
Here, a protocol is described that uses PCR amplification of the DNA fragments, a Gibson assembly cloning kit (which includes chemically competent bacterial cells) to produce custom vectors of 3xFLAG-tagged mouse CstF-64 or mutant CstF-64 to their amino terminal end under the expression of hEF1&#945; promoter1.

<table border="0" cellpadding="0" cellspacing="0" width="553">
	<tbody>
		<tr height="42">
			<td height="42" style="height:42px;width:196px;">Name of Material/ Equipment</td>
			<td style="width:71px;">Company</td>
			<td style="width:119px;">Catalog Number</td>
			<td style="width:167px;">Comments/Description</td>
		</tr>
		<tr height="84">
			<td height="84" style="height:84px;width:196px;">Synthetic double-stranded DNA fragment (sDNA)</td>
			<td style="width:71px;">Integrated DNA Technologies</td>
			<td style="width:119px;"></td>
			<td>We used gBlocks, which can be up to 2 kb in length. However, there are many commercial sources of synthetic DNA available.</td>
		</tr>
		<tr height="42">
			<td height="42" style="height:42px;width:196px;">DNA purification magnetic beads</td>
			<td style="width:71px;">Beckman Coulter</td>
			<td style="width:119px;">A63880</td>
			<td>Agencourt AMPure XP - PCR Purification system</td>
		</tr>
		<tr height="63">
			<td height="63" style="height:63px;width:196px;">Plasmid Isolation Mini Kit</td>
			<td style="width:71px;">Omega Bio-Tek Inc</td>
			<td style="width:119px;">D6942-01</td>
			<td>E.Z.N.A. Plasmid Mini Kit I</td>
		</tr>
		<tr height="63">
			<td height="63" style="height:63px;width:196px;">Gibson Assembly Cloning Kit</td>
			<td style="width:71px;">New England BioLabs</td>
			<td style="width:119px;">E5510S</td>
			<td></td>
		</tr>
		<tr height="63">
			<td height="63" style="height:63px;">DNA polymerase&#160;</td>
			<td style="width:71px;">New England BioLabs</td>
			<td style="width:119px;">M0494S</td>
			<td>Q5 Hot Start High-Fidelity 2X Master Mix</td>
		</tr>
		<tr height="63">
			<td height="63" style="height:63px;width:196px;">DpnI</td>
			<td style="width:71px;">New England BioLabs</td>
			<td style="width:119px;">R0176S</td>
			<td></td>
		</tr>
		<tr height="63">
			<td height="63" style="height:63px;width:196px;">NheI</td>
			<td style="width:71px;">New England BioLabs</td>
			<td style="width:119px;">R3131S</td>
			<td></td>
		</tr>
		<tr height="63">
			<td height="63" style="height:63px;width:196px;">NotI</td>
			<td style="width:71px;">New England BioLabs</td>
			<td style="width:119px;">R3189S</td>
			<td></td>
		</tr>
		<tr height="63">
			<td height="63" style="height:63px;width:196px;">HindIII</td>
			<td style="width:71px;">New England BioLabs</td>
			<td style="width:119px;">R3104S</td>
			<td></td>
		</tr>
		<tr height="42">
			<td height="42" style="height:42px;width:196px;">Name of Material/ Equipment</td>
			<td style="width:71px;">Company</td>
			<td style="width:119px;">Catalog Number</td>
			<td>Comments/Description</td>
		</tr>
		<tr height="42">
			<td height="42" style="height:42px;">Spectrophotometer</td>
			<td style="width:71px;">Thermo Scientific</td>
			<td style="width:119px;"></td>
			<td>NanoDrop device</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:196px;">EditSeq</td>
			<td style="width:71px;">DNASTAR</td>
			<td style="width:119px;"></td>
			<td>Part of Lasergene Core Suite</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:196px;">SeqBuilder</td>
			<td style="width:71px;">DNASTAR</td>
			<td style="width:119px;"></td>
			<td>Part of Lasergene Core Suite</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:196px;">Word</td>
			<td style="width:71px;">Microsoft</td>
			<td style="width:119px;"></td>
			<td>Part of&#160; Microsoft Office</td>
		</tr>
		<tr height="63">
			<td height="63" style="height:63px;">NEBuilder</td>
			<td style="width:71px;">New England BioLabs</td>
			<td style="width:119px;"></td>
			<td>primer generation tool: http://nebuilder.neb.com</td>
		</tr>
		<tr height="63">
			<td height="63" style="height:63px;">NEBioCalculator</td>
			<td style="width:71px;">New England BioLabs</td>
			<td style="width:119px;"></td>
			<td>ligation calculator: http://nebiocalculator.neb.com/#!/ligation</td>
		</tr>
	</tbody>
</table>

generation of plasmid vectors expressing flag-tagged proteins under the regulation of human elongation factor-1&#945; promoter using gibson assembly

Gibson assembly (GA) cloning offers a rapid, reliable, and flexible alternative to conventional DNA cloning methods. We used GA to create customized plasmids for expression of exogenous genes in mouse embryonic stem cells (mESCs). Expression of exogenous genes under the control of the SV40 or human cytomegalovirus promoters diminishes quickly after transfection into mESCs. A remedy for this diminished expression is to use the human elongation factor-1 alpha (hEF1&#945;) promoter to drive gene expression. Plasmid vectors containing hEF1&#945; are not as widely available as SV40- or CMV-containing plasmids, especially those also containing N-terminal 3xFLAG-tags. The protocol described here is a rapid method to create plasmids expressing FLAG-tagged CstF-64 and CstF-64 mutant under the expressional regulation of the hEF1&#945; promoter. GA uses a blend of DNA exonuclease, DNA polymerase and DNA ligase to make cloning of overlapping ends of DNA fragments possible. Based on the template DNAs we had available, we designed our constructs to be assembled into a single sequence. Our design used four DNA fragments: pcDNA 3.1 vector backbone, hEF1&#945; promoter part 1, hEF1&#945; promoter part 2 (which contained 3xFLAG-tag purchased as a double-stranded synthetic DNA fragment), and either CstF-64 or specific CstF-64 mutant. The sequences of these fragments were uploaded to a primer generation tool to design appropriate PCR primers for generating the DNA fragments. After PCR, DNA fragments were mixed with the vector containing the selective marker and the GA cloning reaction was assembled. Plasmids from individual transformed bacterial colonies were isolated. Initial screen of the plasmids was done by restriction digestion, followed by sequencing. In conclusion, GA allowed us to create customized plasmids for gene expression in 5 days, including construct screens and verification.

A workflow of the protocol that was followed is shown in Figure 2A. We wanted to clone CstF-64 and mutant CstF-64 proteins fused to 3xFLAG-tag under the expressional regulation of hEF1&#945; promoter (Figure 2B and Figure 3). A plasmid containing hEF1&#945; followed by 3xFLAG-tag was not available to us. However, the following plasmids were available: pcDNA 3.1 myc-His (A; a generous gift from Michaela Jansen), hEF1&#945; containing plasmid (a generous gift from Mladen Yovchev) and mouse CstF-64 plasmids12 (Figure 3). The entire sequence for the construct(s) was assembled using the nucleotide and text editing applications (Figure 3; see Table of Equipment). Subsequently, the sequence(s) was split in four convenient pieces (Figure 2B, red blocks and Figure 3) corresponding to the available plasmid DNAs. Amplification primers were designed using primer generation tool (see Table of Equipment) with constraints of 4 - 6 fragments with minimal overlap of 25 nt, set up in the &#8220;Change Gibson Assembly Settings&#8221; pop-up window. NheI and NotI restriction sites were included in the primer design for the purpose of identifying properly assembled plasmids. NheI site is located in the primer sequence between pcDNA 3.1 and 5&#8217; end of the hEF1&#945; promoter. NotI site is located after the stop codon (UGA) of CstF-64 and pcDNA 3.1 vector backbone. Upon simultaneous digestion with both enzymes DNA fragment consisting of hEF1&#945; promoter, 3xFLAG and CstF-64 or mutant CstF-64 will be released (see below and Figure 2B). Primers were ordered in the smallest possible scale and desalted. The second part of the hEF1&#945; promoter containing 3xFLAG-tag DNA fragment (490 bp, Figure 2B, Figure 3) was purchased as a single sDNA fragment (see Table of Materials). DNA fragments used in the assembly reaction were amplified using DNA pol (see Table of Materials). DNA fragments of hEF1&#945; promoter part 1, hEF1&#945; promoter part 2, full length and mutant CstF-64 were amplified simultaneously in a separate tubes for 28 cycles (Figure 4A), following the recommendations of the supplier of the DNA pol (see Table of Materials, for each cycle denaturation was 7 sec at 98 &#176;C, annealing 45 sec at 55 &#176;C, elongation 90 sec at 72 &#176;C). Initially, the pcDNA 3.1 backbone was amplified for 22 cycles (using the same conditions as above with the exception of the elongation time, which was set to 3 min at 72 &#176;C). However, the resulting DNA yield was not sufficient to be used in an assembly reaction (Figure 4A). Therefore, an additional amplification was performed to obtain sufficient DNA.
PCR products obtained from a plasmid template must be digested with DpnI restriction enzyme to remove the plasmid DNA, which otherwise would contaminate the resulting assembly reaction products and will produce false-positive drug-resistant bacterial colonies. Therefore, the PCR products were digested with DpnI restriction enzyme, which cleaves methylated and hemi-methylated plasmid DNA isolated from dam+ E. coli strains. PCR products obtained using synthetic DNA fragments, as templates do not need to be digested with DpnI since chemically synthesized DNA does not contain methylated or hemi-methylated bases.
DNA fragments were purified and concentrated over DNA purification magnetic beads (see Table of Materials) as described in the protocol step 4. The PCRs for the pcDNA 3.1 vector backbone were combined together and the amount of DNA purification magnetic beads used was adjusted accordingly. The DNA yield was determined using a spectrophotometer (Table 1 and Table of Equipment). Assembly reactions for CstF-64 and mutant CstF-64 constructs were assembled on ice (Table 1). A 3-fold molar excess of the DNA fragments considered as &#8220;inserts&#8221; was used (Table 1, Figure 3). The final volume of the mixed DNA fragments was adjusted to 10 &#181;l with water and 10 &#181;l of assembly master mix (2x) was added. The reactions were mixed and incubated at 50 &#176;C for 1 hr. Positive control reaction was also assembled according the recommendation of the GA kit manual and incubated simultaneously with the CstF-64 and mutant CstF-64 reactions. As recommended in the protocol, 2 &#181;l of the each of the assembly reactions were transformed in the chemically competent E. coli supplied with the assembly cloning kit (see Table of Materials). The transformation was carried out as described in the kit manual. Positive clones were selected on ampicillin agar/LB plates. 6 colonies per each assembly reaction were randomly selected to be propagated. Plasmid DNAs were isolated using a plasmid isolation mini kit (see Table of Materials). In silico digestion of the constructs with the restriction enzymes NheI and NotI resulted in two fragments with sizes of 4,590 bp, 3,032 bp for CstF-64 and 4,590 bp, 2,711 bp for mutant CstF-64 (Figure 2B and Figure 4B). Digestion with the restriction enzymes HindIII and NotI resulted in three fragments with the following sizes: 5,872 bp, 1005 bp, and 745 bp (CstF-64) and 5,872 bp, 1005 bp, and 424 bp (mutant CstF-64, Figure 2B and Figure 4C). Indeed, digestion of the isolated plasmids displayed the expected characteristic patterns (Figure 4B,C). Note that the 424 bp DNA fragment produced by digestion with HindIII and NotI of the CstF-64 mutant plasmids on Figure 4C is weakly stained due to its small size. 2 out of the 6 isolated plasmids were sent for sequencing. We sequenced the hEF1&#945; promoter, and CstF-64 or mutant CstF-64 parts of the constructs to verify that there are no deletions, insertions or substitutions. We highly recommend sequencing of the DNA constructs resulting from this or any PCR-based protocol. The sequencing showed that one of each sequenced plasmid contained the expected sequence in the region of hEF1&#945;, 3xFLAG-tag and CstF-64 or mutant CstF-64. Each of the other plasmids had a point mutation introduced during the amplification of the corresponding DNA fragment. Expression of the plasmid containing CstF-64 in mouse embryonic stem cells, produced abundant amount of exogenous protein comparable to wild type expression17.
<img alt="Figure 1" src="/files/ftp_upload/52235/52235fig1highres.jpg" width="450" /> 
Figure 1. Schematic representation of the Gibson Assembly mechanism. DNA fragments with overlapping ends were isothermally assembled in a single continuous sequence. The overlapping ends first are chewed back by 5&#8217; exonuclease, which is gradually heat inactivated. Consequently, different DNA fragments with overlapping ends will anneal isothermally. DNA polymerase will fill in the gaps and thermostable DNA ligase ligates the nicks. <a href="https://www.jove.com/files/ftp_upload/52235/52235fig1highres.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 2" src="/files/ftp_upload/52235/52235fig2highres.jpg" width="650" /> 
Figure 2. (A) Flowchart of the protocol described for assembly cloning. (B) Representation of the plasmid, pGA-CstF-64 generated using GA kit. Red &#8211; DNA fragments used in the assembly reaction: pcDNA 3.1; hEF1&#945; promoter part 1(hEF1a &#8211; 1); hEF1&#945; promoter part 2 (hEF1a &#8211; 2) ordered as a synthetic DNA; mouse CstF-64 (mCstF-64). Blue &#8211; open reading frames. Violet &#8211; viral and non-viral promoters. Green &#8211; cleavage and polyadenylation regions. <a href="https://www.jove.com/files/ftp_upload/52235/52235fig2highres.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 3" src="/files/ftp_upload/52235/52235fig3highres.jpg" width="650" /> 
Figure 3. Design of the Gibson assembly CstF-64 plasmid. Black boxes represent the DNA fragments that were available to design a single Gibson assembly CstF-64 in silico sequence. Subsequently, the sequence was divided in four DNA pieces, which were amplified by PCR. Note that due to small size of the 3xFLAG-tag the sequence was designed as a sDNA together with the hEF1&#945; promoter part 2. <a href="https://www.jove.com/files/ftp_upload/52235/52235fig3highres.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 4" src="/files/ftp_upload/52235/52235fig4highres.jpg" width="650" /> 
Figure 4. PCR of the DNA fragments used in the cloning reactions and representative restriction enzyme digestion of the plasmids obtained. (A) Representative PCRs using hot start high-fidelity 2x master mix for the DNA fragments used in assembly reactions: (B) Representative plasmids of hEF1&#945;, full length CstF-64, pcDNA 3.1 construct (pGA-CstF-64) and hEF1&#945;, mutant CstF-64, pcDNA 3.1 construct (pGA-mutCstF-64) digested with NheI and NotI. (C) the same plasmids as in B digested with HindIII and NotI enzymes. <a href="https://www.jove.com/files/ftp_upload/52235/52235fig4highres.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<table border="0" cellpadding="0" cellspacing="0">
	<tbody>
		<tr>
			<td>Name of DNA fragments</td>
			<td>Expected size (bp)</td>
			<td>Concn. (ng/&#181;l)</td>
			<td>Diluted to (ng/&#181;l)</td>
			<td>&#181;l used in GA CstF-64 from Diluted</td>
			<td>&#181;l used in GA mutCstF-64, from Diluted</td>
			<td>Molar ratio (ins:vec)</td>
		</tr>
		<tr>
			<td>pcDNA 3.1 (vector)</td>
			<td>4,618</td>
			<td>158</td>
			<td>undiluted</td>
			<td>1</td>
			<td>1</td>
			<td></td>
		</tr>
		<tr>
			<td>hEF1_ promoter part 1</td>
			<td>825</td>
			<td>213</td>
			<td>75</td>
			<td>1</td>
			<td>1</td>
			<td>3:1</td>
		</tr>
		<tr>
			<td>hEF1_ promoter part 2 for CstF-64</td>
			<td>516</td>
			<td>229</td>
			<td>50</td>
			<td>1</td>
			<td></td>
			<td>3:1</td>
		</tr>
		<tr>
			<td>Cstf-64</td>
			<td>1,796</td>
			<td>161</td>
			<td>undiluted</td>
			<td>1</td>
			<td></td>
			<td>3:1</td>
		</tr>
		<tr>
			<td>hEF1_ promoter part 2 for mutant CstF-64</td>
			<td>516</td>
			<td>199</td>
			<td>50</td>
			<td></td>
			<td>1</td>
			<td>3:1</td>
		</tr>
		<tr>
			<td>mutant CstF-64</td>
			<td>1,448</td>
			<td>201</td>
			<td>171</td>
			<td></td>
			<td>1</td>
			<td>3:1</td>
		</tr>
	</tbody>
</table>
Table 1. Yield of DNA fragments after concentration on magnetic beads, dilution and set up of the assembly reactions.

Watch this Scientific Journal Video about Generation of Plasmid Vectors Expressing FLAG-tagged Proteins Under the Regulation of Human Elongation Factor-1Î± Promoter Using Gibson Assembly at JoVE.com

Generation of Plasmid Vectors Expressing FLAG-tagged Proteins Under the Regulation of Human Elongation Factor-1&amp;#945; Promoter Using Gibson Assembly

Synthesis of custom plasmids is labor and time consuming. This protocol describes the use of Gibson assembly cloning to reduce the work and duration of custom DNA cloning procedure. The protocol described also produces reliable tagged protein constructs for mammalian expression at similar cost to the traditional cut-and-paste DNA cloning.

Generation of Plasmid Vectors Expressing FLAG-tagged Proteins Under the Regulation of Human Elongation Factor-1&#945; Promoter Using Gibson Assembly

Gibson assembly (GA) cloning offers a rapid, reliable, and flexible alternative to conventional DNA cloning methods. We used GA to create customized ...

generation-plasmid-vectors-expressing-flag-tagged-proteins-under

Research

JoVE Journal

Biology

Transformation of Plasmid DNA into E. coli Using the Heat Shock Method

Transformation of plasmid DNA into E. coli using the heat shock method is a basic technique of molecular biology. It consists of inserting a foreign plasmid or ligation product into bacteria. This video protocol describes the traditional method of transformation using commercially available chemically competent bacteria from Genlantis. After a short incubation in ice, a mixture of chemically competent bacteria and DNA is placed at 42&deg;C for 45 seconds (heat shock) and then placed back in ice. SOC media is added and the transformed cells are incubated at 37&deg;C for 30 min with agitation. To be assured of isolating colonies irrespective of transformation efficiency, two quantities of transformed bacteria are plated. This traditional protocol can be used successfully to transform most commercially available competent bacteria. The turbocells from Genlantis can also be used in a novel 3-minute transformation protocol, described in the instruction manual.

Transformation of plasmid DNA into E. coli using the heat shock method is a basic technique of molecular biology. It consists of inserting a foreign ...

Primary Culture and Plasmid Electroporation of the Murine Organ of Corti. 

In all mammals, the sensory epithelium for audition is located along the spiraling organ of Corti that resides within the conch shaped cochlea of the inner ear (fig 1). Hair cells in the developing cochlea, which are the mechanosensory cells of the auditory system, are aligned in one row of inner hair cells and three (in the base and mid-turns) to four (in the apical turn) rows of outer hair cells that span the length of the organ of Corti. Hair cells transduce sound-induced mechanical vibrations of the basilar membrane into neural impulses that the brain can interpret. Most cases of sensorineural hearing loss are caused by death or dysfunction of cochlear hair cells.
An increasingly essential tool in auditory research is the isolation and in vitro culture of the organ explant 1,2,9. Once isolated, the explants may be utilized in several ways to provide information regarding normative, anomalous, or therapeutic physiology. Gene expression, stereocilia motility, cell and molecular biology, as well as biological approaches for hair cell regeneration are examples of experimental applications of organ of Corti explants.
This protocol describes a method for the isolation and culture of the organ of Corti from neonatal mice. The accompanying video includes stepwise directions for the isolation of the temporal bone from mouse pups, and subsequent isolation of the cochlea, spiral ligament, and organ of Corti. Once isolated, the sensory epithelium can be plated and cultured in vitro in its entirety, or as a further dissected micro-isolate that lacks the spiral limbus and spiral ganglion neurons. Using this method, primary explants can be maintained for 7-10 days. As an example of the utility of this procedure, organ of Corti explants will be electroporated with an exogenous DsRed reporter gene. This method provides an improvement over other published methods because it provides reproducible, unambiguous, and stepwise directions for the isolation, microdissection, and primary culture of the organ of Corti.

Primary Culture and Plasmid Electroporation of the Murine Organ of Corti.

This procedure describes a method for the isolation and culture of the murine organ of Corti with or without the spiral limbus and spiral ganglion neurons. We also demonstrate a method for the expression of an exogenous reporter gene in the organ of Corti explant by electroporation.

In all mammals, the sensory epithelium for audition is located along the spiraling organ of Corti that resides within the conch shaped cochlea of the ...

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Through the ectopic expression of four transcription factors, Oct4, Klf4, Sox2 and cMyc, human somatic cells can be converted to a pluripotent state, generating so-called induced pluripotent stem cells (iPSCs)1-4. Patient-specific iPSCs lack the ethical concerns that surround embryonic stem cells (ESCs) and would bypass possible immune rejection. Thus, iPSCs have attracted considerable attention for disease modeling studies, the screening of pharmacological compounds, and regenerative therapies5.
We have shown the generation of transgene-free human iPSCs from patients with different lung diseases using a single excisable polycistronic lentiviral Stem Cell Cassette (STEMCCA) encoding the Yamanaka factors6. These iPSC lines were generated from skin fibroblasts, the most common cell type used for reprogramming. Normally, obtaining fibroblasts requires a skin punch biopsy followed by expansion of the cells in culture for a few passages. Importantly, a number of groups have reported the reprogramming of human peripheral blood cells into iPSCs7-9. In one study, a Tet inducible version of the STEMCCA vector was employed9, which required the blood cells to be simultaneously infected with a constitutively active lentivirus encoding the reverse tetracycline transactivator. In contrast to fibroblasts, peripheral blood cells can be collected via minimally invasive procedures, greatly reducing the discomfort and distress of the patient. A simple and effective protocol for reprogramming blood cells using a constitutive single excisable vector may accelerate the application of iPSC technology by making it accessible to a broader research community. Furthermore, reprogramming of peripheral blood cells allows for the generation of iPSCs from individuals in which skin biopsies should be avoided (i.e. aberrant scarring) or due to pre-existing disease conditions preventing access to punch biopsies.
Here we demonstrate a protocol for the generation of human iPSCs from peripheral blood mononuclear cells (PBMCs) using a single floxed-excisable lentiviral vector constitutively expressing the 4 factors. Freshly collected or thawed PBMCs are expanded for 9 days as described10,11 in medium containing ascorbic acid, SCF, IGF-1, IL-3 and EPO before being transduced with the STEMCCA lentivirus. Cells are then plated onto MEFs and ESC-like colonies can be visualized two weeks after infection. Finally, selected clones are expanded and tested for the expression of the pluripotency markers SSEA-4, Tra-1-60 and Tra-1-81. This protocol is simple, robust and highly consistent, providing a reliable methodology for the generation of human iPSCs from readily accessible 4 ml of blood.

Here we show a simple and effective protocol for the generation of human iPSCs from 3-4 ml of peripheral blood using a single lentiviral reprogramming vector. Reprogramming of readily available blood cells promises to accelerate the utilization of iPSC technology by making it accessible to a broader research community.

Through the ectopic expression of four transcription factors, Oct4, Klf4, Sox2 and cMyc, human somatic cells can be converted to a pluripotent state, ...

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

The characterization of gene expression in cells via measurement of mRNA levels is a useful tool in determining how the transcriptional machinery of the cell is affected by external signals (e.g. drug treatment), or how cells differ between a healthy state and a diseased state. With the advent and continuous refinement of next-generation DNA sequencing technology, RNA-sequencing (RNA-seq) has become an increasingly popular method of transcriptome analysis to catalog all species of transcripts, to determine the transcriptional structure of all expressed genes and to quantify the changing expression levels of the total set of transcripts in a given cell, tissue or organism1,2 . RNA-seq is gradually replacing DNA microarrays as a preferred method for transcriptome analysis because it has the advantages of profiling a complete transcriptome, providing a digital type datum (copy number of any transcript) and not relying on any known genomic sequence3.
Here, we present a complete and detailed protocol to apply RNA-seq to profile transcriptomes in human pulmonary microvascular endothelial cells with or without thrombin treatment. This protocol is based on our recent published study entitled "RNA-seq Reveals Novel Transcriptome of Genes and Their Isoforms in Human Pulmonary Microvascular Endothelial Cells Treated with Thrombin,"4 in which we successfully performed the first complete transcriptome analysis of human pulmonary microvascular endothelial cells treated with thrombin using RNA-seq. It yielded unprecedented resources for further experimentation to gain insights into molecular mechanisms underlying thrombin-mediated endothelial dysfunction in the pathogenesis of inflammatory conditions, cancer, diabetes, and coronary heart disease, and provides potential new leads for therapeutic targets to those diseases.
The descriptive text of this protocol is divided into four parts. The first part describes the treatment of human pulmonary microvascular endothelial cells with thrombin and RNA isolation, quality analysis and quantification. The second part describes library construction and sequencing. The third part describes the data analysis. The fourth part describes an RT-PCR validation assay. Representative results of several key steps are displayed. Useful tips or precautions to boost success in key steps are provided in the Discussion section. Although this protocol uses human pulmonary microvascular endothelial cells treated with thrombin, it can be generalized to profile transcriptomes in both mammalian and non-mammalian cells and in tissues treated with different stimuli or inhibitors, or to compare transcriptomes in cells or tissues between a healthy state and a disease state.

This protocol presents a complete and detailed procedure to apply RNA-seq, a powerful next-generation DNA sequencing technology, to profile transcriptomes in human pulmonary microvascular endothelial cells with or without thrombin treatment. This protocol is generalizable to various cells or tissues affected by different reagents or disease states.

The characterization of gene expression in cells via measurement of mRNA levels is a useful tool in determining how the transcriptional machinery of the ...

Rapid Generation of Amyloid from Native Proteins In vitro

Proteins carry out crucial tasks in organisms by exerting functions elicited from their specific three dimensional folds. Although the native structures of polypeptides fulfill many purposes, it is now recognized that most proteins can adopt an alternative assembly of beta-sheet rich amyloid. Insoluble amyloid fibrils are initially associated with multiple human ailments, but they are increasingly shown as functional players participating in various important cellular processes. In addition, amyloid deposited in patient tissues contains nonproteinaceous components, such as nucleic acids and glycosaminoglycans (GAGs). These cofactors can facilitate the formation of amyloid, resulting in the generation of different types of insoluble precipitates. By taking advantage of our understanding how proteins misfold via an intermediate stage of soluble amyloid precursor, we have devised a method to convert native proteins to amyloid fibrils in vitro. This approach allows one to prepare amyloid in large quantities, examine the properties of amyloid generated from specific proteins, and evaluate the structural changes accompanying the conversion.

Rapid Generation of Amyloid from Native Proteins In vitro

Proteins can either adopt a native structure or misfold into insoluble amyloid. Conditions that favor the misfolding pathway lead to the formation of different types of amyloid fibrils. The methods described here allow rapid conversion of native proteins into amyloid in vitro.

Proteins carry out crucial tasks in organisms by exerting functions elicited from their specific three dimensional folds. Although the native structures ...

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1

Gene expression in different tissues is often controlled by alternative promoters that result in the synthesis of mRNA with unique &#8212; usually untranslated &#8212; first exons. Bcrp1 (Abcg2), the murine orthologue of the ABC transporter Breast Cancer Resistance Protein (BCRP, ABCG2), has at least four alternative promoters that are designated by the corresponding four alternative first exons produced: E1U, E1A, E1B, and E1C. Herein, in-silico protocols are presented to predict alternative promoter usage for Bcrp1. Furthermore, reporter assay methods are described to produce reporter constructs for alternative promoters and to determine the functionality of putative promoters upstream of the alternative first exons that are identified.

With the murine ABC transporter Bcrp1 (Abcg2) as an example, in-silico protocols are presented to detect alternative promoter usage in genes expressed in mouse tissues, and to evaluate the functionality of the alternative promoters identified using reporter assays.

Gene expression in different tissues is often controlled by alternative promoters that result in the synthesis of mRNA with unique &#8212; usually ...

Rapid Verification of Terminators Using the pGR-Blue Plasmid and Golden Gate Assembly

The goal of this protocol is to allow for the rapid verification of bioinformatically identified terminators. Further, the plasmid (pGR-Blue) is designed specifically for this protocol and allows for the quantification of terminator efficiency. As a proof of concept, six terminators were bioinformatically identified in the mycobacteriophage Bernal13. Once identified, terminators were then made as oligonucleotides with the appropriate sticky ends and annealed together. Using Golden Gate Assembly (GGA), terminators were then cloned into pGR-Blue. Under visible light, false positive colonies appear blue and positively transformed colonies are white/yellow. After induction of an arabinose inducible promoter (pBad) with arabinose, colony strength can be determined by measuring the ratio of green fluorescent protein (GFP) produced to red fluorescent protein (RFP) produced. With pGR-Blue, the protocol can be completed in as little as three days and is ideal in an educational setting. Additionally, results show that this protocol is useful as a means for understanding in silico predictions of terminator efficiency related to the regulation of transcription.

This protocol utilizes Golden Gate Assembly and the plasmid pGR-blue to rapidly quantify the strength of terminators found in silico.

The goal of this protocol is to allow for the rapid verification of bioinformatically identified terminators. Further, the plasmid (pGR-Blue) is designed ...

CAPRRESI: Chimera Assembly by Plasmid Recovery and Restriction Enzyme Site Insertion

Here, we present chimera assembly by plasmid recovery and restriction enzyme site insertion (CAPRRESI). CAPRRESI benefits from many strengths of the original plasmid recovery method and introduces restriction enzyme digestion to ease DNA ligation reactions (required for chimera assembly). For this protocol, users clone wildtype genes into the same plasmid (pUC18 or pUC19). After the in silico selection of amino acid sequence regions where chimeras should be assembled, users obtain all the synonym DNA sequences that encode them. Ad hoc Perl scripts enable users to determine all synonym DNA sequences. After this step, another Perl script searches for restriction enzyme sites on all synonym DNA sequences. This in silico analysis is also performed using the ampicillin resistance gene (ampR) found on pUC18/19 plasmids. Users design oligonucleotides inside synonym regions to disrupt wildtype and ampR genes by PCR. After obtaining and purifying complementary DNA fragments, restriction enzyme digestion is accomplished. Chimera assembly is achieved by ligating appropriate complementary DNA fragments. pUC18/19 vectors are selected for CAPRRESI because they offer technical advantages, such as small size (2,686 base pairs), high copy number, advantageous sequencing reaction features, and commercial availability. The usage of restriction enzymes for chimera assembly eliminates the need for DNA polymerases yielding blunt-ended products. CAPRRESI is a fast and low-cost method for fusing protein-coding genes.

Here, we present chimera assembly by plasmid recovery and restriction enzyme site insertion (CAPRRESI), a protocol based on the insertion of restriction enzyme sites into synonym DNA sequences and functional plasmid recovery. This protocol is a fast and low-cost method for fusing protein-coding genes.

Here, we present chimera assembly by plasmid recovery and restriction enzyme site insertion (CAPRRESI). CAPRRESI benefits from many strengths of the ...

Plant Promoter Analysis: Identification and Characterization of Root Nodule Specific Promoter in the Common Bean

The upstream sequences of gene coding sequences are termed as promoter sequences. Studying the expression patterns of promoters are very significant in understanding the gene regulation and spatiotemporal expression patterns of target genes. On the other hand, it is also critical to establish promoter evaluation tools and genetic transformation techniques that are fast, efficient, and reproducible. In this study, we investigated the spatiotemporal expression pattern of the rhizobial symbiosis-specific nodule inception (NIN) promoter of Phaseolus vulgaris in the transgenic hairy roots. Using plant genome databases and analysis tools we identified, isolated, and cloned the P. vulgaris NIN promoter in a transcriptional fusion to the chimeric reporter &#946;-glucuronidase (GUS) GUS-enhanced::GFP. Further, this protocol describes a rapid and versatile system of genetic transformation in the P. vulgaris using Agrobacterium rhizogenes induced hairy roots. This system generates &#8805;2 cm hairy roots at 10 to 12 days after transformation. Next, we assessed the spatiotemporal expression of NIN promoter in Rhizobium inoculated hairy roots at periodic intervals of post-inoculation. Our results depicted by GUS activity show that the NIN promoter was active during the process of nodulation. Together, the present protocol demonstrates how to identify, isolate, clone, and characterize a plant promoter in the common bean hairy roots. Moreover, this protocol is easy to use in non-specialized laboratories.

Promoter expression analyses are crucial to improving the understanding of gene regulation and the spatiotemporal expression of target genes. Herein we present a protocol to identify, isolate, and clone a plant promoter. Further, we describe the characterization of the nodule-specific promoter in the common bean hairy roots.

The upstream sequences of gene coding sequences are termed as promoter sequences. Studying the expression patterns of promoters are very significant in ...

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Low oxygen levels (hypoxia) trigger a variety of adaptive responses with the Hypoxia-inducible factor 1 (HIF-1) complex acting as a master regulator. HIF-1 consists of a heterodimeric oxygen-regulated &#945; subunit (HIF-1&#945;) and constitutively expressed &#946; subunit (HIF-1&#946;) also known as aryl hydrocarbon receptor nuclear translocator (ARNT), regulating genes involved in diverse processes including angiogenesis, erythropoiesis and glycolysis. The identification of HIF-1 interacting proteins is key to the understanding of the hypoxia signaling pathway. Besides the regulation of HIF-1&#945; stability, hypoxia also triggers the nuclear translocation of many transcription factors including HIF-1&#945; and ARNT. Notably, most of the current methods used to study such protein-protein interactions (PPIs) are based on systems where protein levels are artificially increased through protein overexpression. Protein overexpression often leads to non-physiological results arising from temporal and spatial artifacts. Here we describe a modified co-immunoprecipitation protocol following hypoxia treatment using endogenous nuclear proteins, and as a proof of concept, to show the interaction between HIF-1&#945; and ARNT. In this protocol, the hypoxic cells were harvested under hypoxic conditions and the Dulbecco's Phosphate-Buffered Saline (DPBS) wash buffer was also pre-equilibrated to hypoxic conditions before usage to mitigate protein degradation or protein complex dissociation during reoxygenation. In addition, the nuclear fractions were subsequently extracted to concentrate and stabilize endogenous nuclear proteins and avoid possible spurious results often seen during protein overexpression. This protocol can be used to demonstrate endogenous and native interactions between transcription factors and transcriptional co-regulators under hypoxic conditions.

Here we describe a co-immunoprecipitation protocol to study protein-protein interactions between endogenous nuclear proteins under hypoxic conditions. This method is suitable for demonstration of the interactions between transcription factors and transcriptional co-regulators at hypoxia.

Low oxygen levels (hypoxia) trigger a variety of adaptive responses with the Hypoxia-inducible factor 1 (HIF-1) complex acting as a master regulator. ...